Risk of Death in Long-Term Follow-Up of Patients With Apical Hypertrophic Cardiomyopathy
Risk of Death in Long-Term Follow-Up of Patients With Apical Hypertrophic Cardiomyopathy
复制标题
DOI:
10.1016/j.amjcard.2013.02.040
复制
发表时间:
2013-06-15
影响因子:
2.8
通讯作者:
Ommen, Steve R.
中科院分区:
文献类型:
--
作者:
Klarich, Kyle W.;Jost, Christine H. Attenhofer;Ommen, Steve R.
Apical hypertrophic cardiomyopathy (HC) has been considered a "benign" form of HC, with limited data on long-term outcome. We compared apical HC patients with a non-HC, age- and gender-matched Minnesota white population to identify outcomes and prognostic factors. Between 1976 and 2006, 193 patients (62% men) with apical HC were seen at our clinic. Their most recent echocardiographic examinations were reviewed. Mean +/- SD age at first presentation was 58 +/- 17 years. A family history of HC or sudden cardiac death (SCD) was reported by 43 patients (22%); coronary artery disease was known in 22 (11%). An apical pouch was present in 29 patients, including an apical aneurysm in 6 and apical dilatation with hypokinesis in 23. Median follow-up (187 patients [97%]) was 78 months (range, 1-350). Death from all causes occurred in 55 patients (29%; 33 women) at a mean age of 72 years (range, 20-92). During follow-up, more women had heart failure (p = 0.001), atrial fibrillation (p = 0.009), or died (p < 0.001) than men. Survival was worse than expected (p = 0.001); the observed versus expected 20-year survival was 47% versus 60%. SCD, resuscitated cardiac arrest, and/or defibrillator discharge was observed in 11 patients (6%) during follow-up. Multivariate predictors of decreased survival were higher age at baseline (p < 0.001), female gender (p < 0.001), and atrial fibrillation at baseline (p = 0.06). In conclusion, apical HC in this population was associated with increased mortality, especially in women. Because apical HC is less benign than previously suspected, careful longitudinal care is warranted. (C) 2013 Elsevier Inc. All rights reserved.